Detalhe da pesquisa
1.
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Hematol Oncol
; 41(1): 50-60, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251440
2.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467145
3.
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Am J Hematol
; 96(3): 292-301, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284999
4.
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.
Br J Haematol
; 188(2): 249-258, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385309
5.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816326
6.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol
; 37(4): 368-374, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325190
7.
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
Br J Haematol
; 177(4): 588-596, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419517
8.
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
Br J Haematol
; 174(4): 541-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27172403
9.
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance.
Hematol Oncol
; 32(3): 133-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24254547
10.
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
Front Oncol
; 13: 1152467, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36998457
11.
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
J Mol Diagn
; 24(8): 893-900, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710027
12.
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin.
Br J Haematol
; 174(2): 329-31, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26455504
13.
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia.
Hemasphere
; 5(3): e543, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655199
14.
Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.
Front Oncol
; 9: 726, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448230
15.
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
Front Oncol
; 9: 689, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31555576
16.
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia.
Leuk Lymphoma
; 62(3): 755-757, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150814
17.
Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network.
Leuk Lymphoma
; 57(2): 400-410, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115509
18.
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.
Hemasphere
; 5(10): e639, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514343
19.
Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Leuk Lymphoma
; 60(11): 2838-2840, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050551
20.
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Clin Cancer Res
; 20(24): 6398-405, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316810